The in vivo decrease of beta-alanine-2-oxoglutarate aminotransferase activity caused by 6-azauracil and 5-fluorouracil.
D000612:4-Aminobutyrate Transaminase / Q000037:antagonists & inhibitors*; D000818:Animals; D001921:Brain / Q000378:metabolism; D005472:Fluorouracil / Q000494:pharmacology*; D008099:Liver / Q000378:metabolism; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D000637:Transaminases / Q000037:antagonists & inhibitors*; D014498:Uracil / Q000031:analogs & derivatives* / Q000494:pharmacology*; D015091:beta-Alanine / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D015091:beta-Alanine; D005680:gamma-Aminobutyric Acid; D014498:Uracil; D000637:Transaminases; D000612:4-Aminobutyrate Transaminase; C100248:azauracil; D005472:Fluorouracil